Key Highlights
- AEHR shares declined 9.1% to $132.37 during Tuesday’s session, accompanied by 79% lower trading activity
- Analysts maintain a consensus “Buy” recommendation with an average target of $136.67
- Jefferies recently launched coverage with a “Buy” rating and aggressive $175 target price
- Company executives and directors offloaded 109,475 shares valued at $13.8 million in recent months
- Major institutional holders like Vanguard and UBS control approximately 69.7% of outstanding shares
Shares of Aehr Test Systems (AEHR) experienced a sharp 9.1% decline during Tuesday’s trading session, closing at $132.37 after opening at the previous day’s close of $145.61.
Trading activity was significantly subdued. Approximately 520,330 shares exchanged hands during the session, marking a dramatic 79% decline compared to the typical daily volume of 2,424,321 shares.
The stock’s 12-month trading pattern reveals substantial volatility. AEHR bottomed at $16.38 during this period before surging to a recent peak of $147.40.
At current valuation levels, the semiconductor testing equipment manufacturer commands a market capitalization of approximately $4.03 billion. The company trades at a P/E ratio of -519.12, while its beta of 3.10 signals exceptional price volatility compared to broader market movements.
Wall Street Maintains Bullish Stance
The recent price decline hasn’t dampened analyst enthusiasm for AEHR. The consensus rating remains firmly in “Buy” territory, supported by an average price objective of $136.67.
Jefferies launched coverage on the stock this week, assigning a “Buy” rating alongside an ambitious $175 price target. This represents one of the most optimistic outlooks currently published by Wall Street firms.
Both Freedom Capital and Zacks Research elevated their ratings to “Strong Buy” during July. Wall Street Zen also revised its position during the same period, upgrading from “Sell” to “Hold.”
Craig Hallum maintained its “Buy” recommendation in July, setting a $125 price objective. In contrast, Weiss Ratings took a more pessimistic view, lowering its grade from “Sell (D)” to “Sell (E+)” at the end of July.
Current analyst coverage includes two “Strong Buy” recommendations, four “Buy” ratings, and a single “Sell” rating across the seven firms tracking the stock.
Executive Stock Dispositions Raise Eyebrows
Recent insider trading activity has captured market attention. Company executives and board members collectively disposed of 109,475 shares valued at $13.8 million during the past three months.
Chief Operating Officer Adil Engineer offloaded 15,000 shares on August 12 at an average execution price of $131.02, generating proceeds of $1.97 million. This transaction reduced his ownership position by 24.2%.
Executive Vice President Alberto Salamone divested 9,672 shares on August 13 at $127.72 per share, receiving approximately $1.24 million. His holdings decreased by 18.7% following this sale.
Board Director Howard T. Slayen sold 20,000 shares on August 4 at $108.30 each, completing a transaction valued at $2.17 million. This reduced his stake by roughly 12%.
Company insiders currently maintain ownership of 6.8% of total outstanding shares.
Meanwhile, institutional activity shows continued interest. Royal Bank of Canada expanded its position by 15.3% during the first quarter, purchasing 7,968 additional shares for a total of 59,939. Vanguard increased its stake by 2.2%, while UBS substantially grew its holdings by 55.7%. Institutional investors collectively control 69.69% of the company.
Technical indicators show the 50-day moving average at $93.83 and the 200-day moving average at $72.59, both substantially below current trading levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
